Caucuses & Working Groups

Washington state coalition advocating supervised psilocybin access legislation and coalition-based policy campaigns for veterans, first responders, and affected communities.

Statutorily created Colorado advisory board providing implementation recommendations for natural medicine regulation, safety standards, licensing architecture, and program oversight priorities.

Bipartisan U.S. congressional caucus focused on advancing evidence-informed psychedelic policy pathways, with a recurring emphasis on veterans mental health and federal research support.

Independent multidisciplinary working group assessing evidence-evaluation frameworks for psychedelic therapies to inform regulators and policy design.

Nonprofit organizer and host of the Psychedelic Science conference series, alongside broader educational and policy programming.

State advisory board charged with issuing recommendations to Oregon Health Authority on psilocybin services implementation, professional standards, public health safeguards, and operational controls.

European multi-stakeholder alliance coordinating advocacy, policy dialogue, and member working groups to improve access, reimbursement, and responsible integration of psychedelic therapies.

Washington, D.C.-based nonprofit advocacy organization focused on federal and state psychedelic policy, lawmaker education, and coalition-building for safe and equitable access.

European advocacy platform convening policymakers, regulators, researchers, and businesses to develop EU regulatory pathways for psychedelic therapies.

Veteran-led nonprofit coalition advocating federal and state policy reform to expand access to psychedelic-assisted therapies and reduce veteran suicide.